Vascular dysfunction in a transgenic model of Alzheimer's disease: Effects of CB1R and CB2R cannabinoid agonists

  1. Navarro-Dorado, J.
  2. Villalba, N.
  3. Prieto, D.
  4. Brera, B.
  5. Martín-Moreno, A.M.
  6. Tejerina, T.
  7. de Ceballos, M.L.
Aldizkaria:
Frontiers in Neuroscience

ISSN: 1662-453X,  1662-4548

Argitalpen urtea: 2016

Alea: 10

Zenbakia: SEP

Mota: Artikulua

DOI: 10.3389/FNINS.2016.00422 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus